UniProtKB/Swiss-Prot P43626: Variant p.Leu135Pro

• Variant information
• Sequence information
• Literature citations
• All

Variant information

Variant position: 135 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: LB/B The variants are classified into three categories: LP/P, LB/B and US.

• LP/P: likely pathogenic or pathogenic.
• LB/B: likely benign or benign.
• US: uncertain significance

Residue change: From Leucine (L) to Proline (P) at position 135 (L135P, p.Leu135Pro). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

• Lowest score: -4 (low probability of substitution).
• Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources: Links to websites of interest for the variant.

• Variant rs11673144 [ dbSNP | Ensembl ]

Sequence information

Variant position: 135 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 348 The length of the canonical sequence.
Location on the sequence: SDPLDIVIIGLYEKPSLSAQ L GPTVLAGENVTLSCSSRSSY The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

• Type: the type of sequence feature.
• Positions: endpoints of the sequence feature.
• Description: contains additional information about the feature.

Type	Positions	Description
Chain	22 – 348	Killer cell immunoglobulin-like receptor 2DL1
Topological domain	22 – 245	Extracellular
Glycosylation	144 – 144	N-linked (GlcNAc...) asparagine
Beta strand	130 – 135

Literature citations

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.
Colonna M.; Samaridis J.;
Science 268:405-408(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS PRO-37 AND PRO-135; Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.
Wagtmann N.; Biassoni R.; Cantoni C.; Verdiani S.; Malnati M.S.; Vitale M.; Bottino C.; Moretta L.; Moretta A.; Long E.O.;
Immunity 2:439-449(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); PROTEIN SEQUENCE OF 22-45; VARIANTS PRO-37 AND PRO-135; Human diversity in killer cell inhibitory receptor genes.
Uhrberg M.; Valiante N.M.; Shum B.P.; Shilling H.G.; Lienert-Weidenbach K.; Corliss B.; Tyan D.; Lanier L.L.; Parham P.;
Immunity 7:753-763(1997)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT PRO-135; Variants of KIR identified in Japanese donors.
Yawata N.; Yawata M.; Parham P.;
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS PHE-5; PRO-37 AND PRO-135;